DOCSLIB.ORG

Deaths from Poisoning, by Sex and Cause, Scotland, 2009

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Deaths from Poisoning, by Sex and Cause, Scotland, 2009 Table 6.12 Deaths from poisoning, by sex and cause, Scotland, 2009 ICD code(s), cause of death and substance(s) * Both Males Females ALL DEATHS FROM POISONING 762 531 231 ACCIDENTS X40 - X49 Accidental poisoning by and exposure to … 97 68 29 X40 - Nonopioid analgesics, antipyretics and antirheumatics Paracetamol 211 X41 - Antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified Amitriptyline, Alcohol 101 Amitriptyline, Venlafaxine, Paracetamol 110 Amphetamine 110 Benzodiazepine, Morphine, Diamorphine, Alcohol || 110 Carbamazepine, Citalopram 110 Citalopram, Promethazine 101 Citalopram, Zopiclone, Alcohol 101 Clozapine 101 Clozapine || Sertraline 101 Clozapine, Cocaine || Diazepam, Alcohol 101 Diazepam 110 Diazepam, Alcohol 110 Diazepam, Dihydrocodeine 110 Diazepam, Temazepam, Methadone 110 Fluoxetine 110 Gamma hydroxybutyrate 101 Trazodone, Codeine, Propranolol, Alcohol 110 Venlafaxine 202 Zopiclone, Alcohol || 101 X42 - Narcotics and psychodysleptics [hallucinogens], not elsewhere classified Buprenorphine, Alcohol || Diazepam 110 Co-codamol 101 Co-codamol, Alcohol 101 Cocaine || Alcohol 110 Cocaine || Codeine, Paracetamol 110 Cocaine || Paracetamol, Codeine, Alcohol 110 Cocaine, Heroin, Alcohol || Diazepam 110 Codeine, Dihydrocodeine || 110 Codeine, Venlafaxine, Alcohol 101 Diazepam, Alcohol 110 Dihydrocodeine 110 Dihydrocodeine || Paracetamol, Duloxetine, Alcohol 110 Dihydrocodeine, Alcohol 211 Dihydrocodeine, Amitriptyline 101 Dihydrocodeine, Diazepam || Codeine, Trazodone 110 Dihydrocodeine, Hydrocodone || Amphetamine, Mirtazapine, Cannabis 1 0 1 Dihydrocodeine, Methadone, Alcohol || Diazepam, Chlordiazepoxide 1 1 0 Fentanyl, Alcohol 110 Heroin || 110 Heroin || Diazepam 220 Heroin || Diazepam, Alcohol 110 Heroin || Diazepam, Cannabis 110 Heroin || Diazepam, Cocaine, Alcohol 110 Heroin || Mirtazapine 110 Heroin, Alcohol || 110 Heroin, Alcohol || Diazepam 110 Heroin, Alcohol || Diazepam, Citalopram 220 Heroin, Alcohol || Diazepam, Cocaine 110 Heroin, Alcohol || Diazepam, Fluoxetine, Quetiapine 1 1 0 Heroin, Chlordiazepoxide, Methadone, Alcohol || 110 Heroin, Cocaine, Alcohol || Diazepam, Tramadol 110 Heroin, Diazepam 110 Heroin, Methadone || 110 Heroin, Methadone, Promethazine 110 MDMA || Alcohol 110 Methadone || Dihydrocodeine, Alcohol 110 Methadone, Alcohol || 110 Methadone, Alcohol || Citalopram, Procyclidine, Valproic acid, Diazepam 1 1 0 Methadone, Citalopram, Alcohol || 101 Methadone, Heroin, Cocaine, Diazepam, Dihydrocodeine 1 1 0 Methadone, Mephedrone 101 Morphine || 101 Morphine || Diazepam, Alcohol 101 Morphine, Alcohol || 211 * where it appears, "||" distinguishes between substances which (i) were implicated in, or potentially contributed to, the cause of death; and (ii) were present but were not considered to have had any direct conribution to the death. Please see the note at the end of the table. General Register Office for Scotland, (c) Crown Copyright 2010 Table 6.12 (continued) Deaths from poisoning, by sex and cause, Scotland, 2009 ICD code(s), cause of death and substance(s) * Both Males Females Morphine, Codeine, Paracetamol, Alcohol 110 Morphine, Tramadol, Diazepam 101 Opiate 101 Opiate, Zopiclone 110 Oxycodone, Midazolam 110 Tramadol 101 Tramadol, Zopiclone, Amitriptyline 101 X43 - Other drugs acting on the autonomic nervous system Propranolol, Dihydrocodeine, Alcohol 101 X44 - Other and unspecified drugs, medicaments and biological substances Bzp, Lignocaine, Alcohol || 110 Insulin 110 Unspecified drug 211 X46 - Organic solvents and halogenated hydrocarbons and their vapours Hydrocarbon, Methadone, Methanol 110 X47 - Other gases and vapours Butane, Isobutane, Propane || Codeine 101 Carbon monoxide 110 X49 - Other and unspecified chemicals and noxious substances Asbestos 12 12 0 INTENTIONAL SELF-HARM X60 -X69 Intentional self-poisoning by and exposure to … 126 71 55 X60 - Nonopioid analgesics, antipyretics and antirheumatics Ibuprofen 101 Paracetamol 936 Paracetamol || 101 Paracetamol, Co-codamol 312 Paracetamol, Naproxen 101 X61 - Antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified Amitriptyline 422 Amitriptyline || Alcohol 110 Amitriptyline || Nortriptyline 110 Amitriptyline, Chlorpromazine 110 Amitriptyline, Fluoxetine, Ethylene, Glycol 101 Amitriptyline, Tramadol 101 Barbiturate 110 Butobarbital || Diazepam, Morphine, Temazepam, Metoclopramide, Paracetamol, Ondansetron 1 1 0 Carbamazepine, Heroin 110 Citalopram 110 Citalopram, Dihydrocodeine || Propranolol, Benzodiazepine, Amphetamine, Methadone, Cocaine, Alcohol 1 1 0 Citalopram, Insulin || 110 Citalopram, Olanzapine 101 Citalopram, Tramadol 101 Dothiepin 211 Dothiepin, Alcohol 101 Dothiepin, Paracetamol 110 Dothiepin, Paracetamol, Alcohol || 110 Dothiepin, Tramadol || 110 Gabapentin, Carbamazepine, Dihydrocodeine || 101 Mirtazapine 101 Mirtazapine, Benzodiazepine, Alcohol 110 Mirtazapine, Paracetamol 101 Mirtazapine, Tramadol 110 Mirtazapine, Unspecified drug || Alcohol 110 Olanzapine 110 Olanzapine, Diazepam, Alcohol 110 Pentobarbital, Alcohol 110 Pentobarbitone 110 Phenytoin 101 Prothiaden 101 Quetiapine, Alcohol 110 Quetiapine, Venlafaxine, Alcohol || 101 Quetiapine, Zopiclone 101 Trazodone, Codeine 110 Valproic acid || Temazepam, Lamotrigine 101 Venlafaxine 211 * where it appears, "||" distinguishes between substances which (i) were implicated in, or potentially contributed to, the cause of death; and (ii) were present but were not considered to have had any direct conribution to the death. Please see the note at the end of the table. General Register Office for Scotland, (c) Crown Copyright 2010 Table 6.12 (continued) Deaths from poisoning, by sex and cause, Scotland, 2009 ICD code(s), cause of death and substance(s) * Both Males Females Venlafaxine, Chlorpheniramine 110 Zopiclone, Alcohol 110 Zopiclone, Diazepam 101 X62 - Narcotics and psychodysleptics [hallucinogens], not elsewhere classified Benzodiazepine, Morphine, Diamorphine || Dosulepin, Citalopram, Cannabis 1 1 0 Co-codamol 303 Co-codamol, Fluoxetine 101 Codeine 110 Codeine || Temazepam, Morphine 101 Codeine, Alcohol || 101 Codeine, Chlorpromazine, Paracetamol 110 Codeine, Dihydrocodeine || Citalopram, Mirtazapine, Amitriptyline, Chlorpheniramine, Chlorpromazine, Diazepam, 101 Codeine, Insulin 110 Dextropropoxyphene 101 Dihydrocodeine 303 Dihydrocodeine || 110 Dihydrocodeine || Diazepam 110 Dihydrocodeine || Diazepam, Paracetamol, Co-dydramol 1 1 0 Dihydrocodeine, Codeine, Diazepam || 110 Dihydrocodeine, Codeine, Diazepam, Alcohol 110 Dihydrocodeine, Paracetamol, Alcohol 110 Heroin || Codeine, Noscapine, Risperidone 101 Methadone, Temazepam, Codeine || 101 Morphine 110 Morphine, Alcohol 110 Morphine, Diamorphine, Benzodiazepine, Fluoxetine, Alcohol || Diltiazem 1 1 0 Oxycodone, Fluoxetine, Diazepam, Alcohol || 101 Tramadol 330 Tramadol, Citalopram 110 Tramadol, Codeine 101 Tramadol, Propranolol 101 Tramadol, Trazodone 110 X63 - Other drugs acting on the autonomic nervous system Propranolol 110 Propranolol, Mirtazapine, Zopiclone, Alcohol || 110 Propranolol, Sertraline, Amitriptyline 101 X64 - Other and unspecified drugs, medicaments and biological substances Chloroquine || 110 Colchicine 110 Diltiazem 211 Helium 220 Insulin 321 Insulin || 101 Ketamine, Dihydrocodeine || Chlordiazepoxide, Diazepam, Alcohol 1 0 1 Unspecified drug 321 Verapamil, Paroxetine 101 X65 - Alcohol Alcohol 211 X67 - Other gases and vapours Butane, Propane || Heroin, Methadone, Diazepam 110 Carbon monoxide 871 Combustion gas 110 X69 - Other and unspecified chemicals and noxious substances Caustic soda 101 Cyanide 110 EVENTS OF UNDETERMINED INTENT Y10 - Y19 Poisoning by and exposure to … 114 72 42 Y10 - Nonopioid analgesics, antipyretics and antirheumatics Ibuprofen, Alcohol 101 Paracetamol 752 Paracetamol, Co-codamol || Chlordiazepoxide, Diazepam 1 1 0 Y11 - Antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified Amisulpride || 101 Amitriptyline 202 Amitriptyline, Alcohol 211 * where it appears, "||" distinguishes between substances which (i) were implicated in, or potentially contributed to, the cause of death; and (ii) were present but were not considered to have had any direct conribution to the death. Please see the note at the end of the table. General Register Office for Scotland, (c) Crown Copyright 2010 Table 6.12 (continued) Deaths from poisoning, by sex and cause, Scotland, 2009 ICD code(s), cause of death and substance(s) * Both Males Females Amitriptyline, Dihydrocodeine 101 Amitriptyline, Gamma hydroxybutyrate 101 Amitriptyline, Nortriptyline, Diazepam 101 Amitriptyline, Solpadol 110 Amitriptyline, Tramadol 110 Amphetamine, Amiodarone 101 Benzodiazepine, Dihydrocodeine, Alcohol 101 Chlorpromazine, Diazepam 101 Citalopram || Methadone, Diazepam, Temazepam 110 Clomipramine || Chlorpromazine, Alcohol 101 Clozapine 101 Diazepam 110 Diazepam, Temazepam, Alcohol 101 Gamma hydroxybutyrate || Alcohol 110 Methocarbamol, Alcohol 101 Mirtazapine, Alcohol 101 Olanzapine || Fluoxetine, Alcohol 110 Paroxetine, Alprazolam, Diazepam, Alcohol 101 Sedative, Alcohol 110 Temazepam, Alcohol 101 Venlafaxine 110 Y12 - Narcotics and psychodysleptics [hallucinogens], not elsewhere classified Buprenorphine, Diazepam 101 Co-proxamol, Tramadol || Amitriptyline, Fluoxetine 110 Cocaine, Benzoylecognine || 110 Cocaine, Dihydrocodeine, Alcohol || Paracetamol 110 Codeine 110 Codeine, Alcohol 110 Codeine, Imipramine, Paracetamol, Morphine, Diazepam, Mirtazapine || Alcohol 1 1 0 Dihydrocodeine
Load more

Recommended publications
  • Smumedical Journal
    SMU Medical Journal ISSN : 2349 – 1604 (Volume – 4, No. 1, January 2017) Review Article Indexed in SIS (USA), ASI (Germany), I2OR & i-Scholar (India), SJIF (Morocco) and Cosmos Foundation (Germany) databases. Impact Factor: 3.835 (SJIF) Analytical Aspects with Brief Overview of Depressants Sandeep Kumar1 Nand Gopal Giri2 Ashok Kumar Jaiswal3* Anil Kumar Jaiswal4 1M.Sc. (Forensic Science), LNJN NICFS, New Delhi 110085, 2Assistant Professor, Department of Chemistry, Shivaji College (University of Delhi) Raja Garden, New Delhi 110 027, 3Dept. of Forensic Medicine and toxicology, All India institute of Medical Sciences, New Delhi 110 029.4Assistant Professor, Department of Mathematics, St. Andrew’s PG College, Gorakhpur, UP. *Corresponding author Manuscript received : 30.10.2016 Manuscript accepted: 21.11.2016 Abstract Depressants are drugs that slow down the functions of the central nervous system (CNS). These drugs are used to reduce anxiety and insomnia without drowsiness. The depressants cause relaxed feeling if used in small quantity but cause unconsciousness, vomiting and even death if taken in high quantity. It affects concentration and coordination of a person by slowing down his/ her ability to respond in unexpected situations. These drugs are also attributed for their physiological and psychological effects, eventually in large dose it become lethal. The different 142 SMU Medical Journal, Volume – 4, No. – 1, January, 2017 physical and chemical features of some very often used depressants are discussed in this manuscript. Keyword: Depressant, TLC, UV spectroscopy, HPLC, GLC etc. Introduction The classical depressants are hypnotics (which induce sleep), most antianxiety medicine (diazepam or valium), muscle spasm prevent seizure, but these drugs rapidly develop dependence and tolerance which finally leads to coma and death, so use of these drugs is highly unsafe.
    [Show full text]
  • Introduced B.,Byhansen, 16
    LB301 LB301 2021 2021 LEGISLATURE OF NEBRASKA ONE HUNDRED SEVENTH LEGISLATURE FIRST SESSION LEGISLATIVE BILL 301 Introduced by Hansen, B., 16. Read first time January 12, 2021 Committee: Judiciary 1 A BILL FOR AN ACT relating to the Uniform Controlled Substances Act; to 2 amend sections 28-401, 28-405, and 28-416, Revised Statutes 3 Cumulative Supplement, 2020; to redefine terms; to change drug 4 schedules and adopt federal drug provisions; to change a penalty 5 provision; and to repeal the original sections. 6 Be it enacted by the people of the State of Nebraska, -1- LB301 LB301 2021 2021 1 Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2 2020, is amended to read: 3 28-401 As used in the Uniform Controlled Substances Act, unless the 4 context otherwise requires: 5 (1) Administer means to directly apply a controlled substance by 6 injection, inhalation, ingestion, or any other means to the body of a 7 patient or research subject; 8 (2) Agent means an authorized person who acts on behalf of or at the 9 direction of another person but does not include a common or contract 10 carrier, public warehouse keeper, or employee of a carrier or warehouse 11 keeper; 12 (3) Administration means the Drug Enforcement Administration of the 13 United States Department of Justice; 14 (4) Controlled substance means a drug, biological, substance, or 15 immediate precursor in Schedules I through V of section 28-405. 16 Controlled substance does not include distilled spirits, wine, malt 17 beverages, tobacco, hemp, or any nonnarcotic substance if such substance 18 may, under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
    [Show full text]
  • Laws 2021, LB236, § 4
    LB236 LB236 2021 2021 LEGISLATIVE BILL 236 Approved by the Governor May 26, 2021 Introduced by Brewer, 43; Clements, 2; Erdman, 47; Slama, 1; Lindstrom, 18; Murman, 38; Halloran, 33; Hansen, B., 16; McDonnell, 5; Briese, 41; Lowe, 37; Groene, 42; Sanders, 45; Bostelman, 23; Albrecht, 17; Dorn, 30; Linehan, 39; Friesen, 34; Aguilar, 35; Gragert, 40; Kolterman, 24; Williams, 36; Brandt, 32. A BILL FOR AN ACT relating to law; to amend sections 28-1202 and 69-2436, Reissue Revised Statutes of Nebraska, and sections 28-401 and 28-405, Revised Statutes Cumulative Supplement, 2020; to redefine terms, change drug schedules, and adopt federal drug provisions under the Uniform Controlled Substances Act; to provide an exception to the offense of carrying a concealed weapon as prescribed; to define a term; to change provisions relating to renewal of a permit to carry a concealed handgun; to provide a duty for the Nebraska State Patrol; to eliminate an obsolete provision; to harmonize provisions; and to repeal the original sections. Be it enacted by the people of the State of Nebraska, Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2020, is amended to read: 28-401 As used in the Uniform Controlled Substances Act, unless the context otherwise requires: (1) Administer means to directly apply a controlled substance by injection, inhalation, ingestion, or any other means to the body of a patient or research subject; (2) Agent means an authorized person who acts on behalf of or at the direction of another person but does not include a common or contract carrier, public warehouse keeper, or employee of a carrier or warehouse keeper; (3) Administration means the Drug Enforcement Administration of the United States Department of Justice; (4) Controlled substance means a drug, biological, substance, or immediate precursor in Schedules I through V of section 28-405.
    [Show full text]
  • A Rapid Method of Identifying Particular Barbiturate Derivatives in Small Samples of Blood by Paper Chromatography by J
    J Clin Pathol: first published as 10.1136/jcp.7.1.61 on 1 February 1954. Downloaded from J. clin. Path. (1954), 7, 61. A RAPID METHOD OF IDENTIFYING PARTICULAR BARBITURATE DERIVATIVES IN SMALL SAMPLES OF BLOOD BY PAPER CHROMATOGRAPHY BY J. T. WRIGHT From the Medical Unit, The London Hospital (RECEIVED FOR PUBLICATION AUGUST 4, 1953) The quantitative estimation of barbiturates in present method sacrifices certain refinements in the blood by ultra-violet spectrophotometry (Gold- interests of speed, since a delayed report is of little baum, 1948; Walker, Fisher, and McHugh, 1948; use to the clinician. Born, 1949; Lous, 1950; Wright and Johns, 1953) is of limited value unless the particular barbiturate Principle derivative is known or can be identified. Goldbaum Barbituric acid derivatives are selectively distributed (1952) described an ultra-violet spectrophotometric between suitably buffered filter paper and a chloro- technique by which he claimed to make such iden- form moving phase. tification, but many workers with experience in this Materials copyright. field will prefer to rely on more direct methods of qualitative analysis. For general purposes the Re-distilled chloroform, Whatman No. 1 filter paper strips, stock solutions of M-20 sodium carbonate and micro-crystalline method of Turfitt (1948) is suit- M-20 borax for making suitable buffers, and a " hano- able if urine or gastric contents are available, via chromatolite" lamp are required. though even then it is always best to confirm the identification by extraction and mixed melting Method point determination. Cases of barbiturate poison- Descending chromatograms are run in a glass tank http://jcp.bmj.com/ ing frequently occur, however, where such material measuring 25 x 25 x 60 cm.
    [Show full text]
  • EXHIBIT a – TEST NAME DESCRIPTIONS Item Test Name Description No
    EXHIBIT A – TEST NAME DESCRIPTIONS Item Test Name Description No. 1. Postmortem, Basic, Blood 11-Hydroxy Delta-9 THC, 6-Monoacetylmorphine – Free, 7-Amino Clonazepam, Acetone, Acetyl Fentanyl, Alpha-Hydroxyalprazolam, Alprazolam, Amobarbital, Amphetamine, Amphetamines, Barbiturates, Benzodiazepines, Benzoylecgonine, Blood Alcohol Concentration (BAC), Buprenorphine – Free, Buprenorphine / Metabolite, Butabarbital, Butalbital, Cannabinoids, Chlordiazepoxide, Clobazam, Clonazepam, Cocaethylene, Cocaine, Cocaine / Metabolites, Codeine – Free, Delta-9 Carboxy THC, Delta-9 THC Desalkylflurazepam, Diazepam, Dihydrocodeine / Hydrocodol – Free, EDDP, Ephedrine, Estazolam, Ethanol, Fentanyl, Fentanyl / Acetyl Fentanyl, Flurazepam, Hydrocodone – Free, Hydromorphone – Free, Hydroxyethylflurazepam, Hydroxytriazolam, Isopropanol, Lorazepam, MDA, MDEA, MDMA, Methadone, Methadone / Metabolite, Methamphetamine, Methamphetamine / MDMA, Methanol, Midazolam, Morphine - Free, Norbuprenorphine - Free, Nordiazepam, Norfentanyl, Norpseudoephedrine, Opiates, Oxazepam, Oxycodone - Free, Oxycodone / Oxymorphone, Pentobarbital, Phencyclidine, Phenobarbital,Phentermine, Phenylpropanolamine, Pseudoephedrine, Secobarbital, Temazepam, Triazolam 2. Postmortem, Basic, Tissue 11-Hydroxy Delta-9 THC, 6-Monoacetylmorphine – Free, 7-Amino Clonazepam, Acetone, Acetyl Fentanyl, Alpha-Hydroxyalprazolam, Alprazolam, Amobarbital, Amphetamine, Amphetamines, Barbiturates, Benzodiazepines, Benzoylecgonine, Blood Alcohol Concentration (BAC), Buprenorphine – Free, Buprenorphine / Metabolite,
    [Show full text]
  • 201 PART 329—HABIT-FORMING DRUGS Subpart A—Derivatives
    Food and Drug Administration, HHS § 329.1 section 502(e) of the Federal Food, PART 329ÐHABIT-FORMING DRUGS Drug, and Cosmetic Act. (d) The statement expressing the Subpart AÐDerivatives Designated as amount (percentage) of alcohol present Habit Forming in the product shall be in a size reason- ably related to the most prominent Sec. printed matter on the panel or label on 329.1 Habit-forming drugs which are chem- which it appears, and shall be in lines ical derivatives of substances specified in generally parallel to the base on which section 502(d) of the Federal Food, Drug, the package rests as it is designed to be and Cosmetic Act. displayed. (e) For a product to state in its label- Subpart BÐLabeling ing that it is ``alcohol free,'' it must 329.10 Labeling requirements for habit- contain no alcohol (0 percent). forming drugs. (f) For any OTC drug product in- tended for oral ingestion containing Subpart CÐExemptions over 5 percent alcohol and labeled for use by adults and children 12 years of 329.20 Exemption of certain habit-forming age and over, the labeling shall contain drugs from prescription requirements. the following statement in the direc- AUTHORITY: 21 U.S.C. 352, 353, 355, 371. tions section: ``Consult a physician for use in children under 12 years of age.'' SOURCE: 39 FR 11736, Mar. 29, 1974, unless (g) For any OTC drug product in- otherwise noted. tended for oral ingestion containing over 0.5 percent alcohol and labeled for Subpart AÐDerivatives use by children ages 6 to under 12 years Designated as Habit Forming of age, the labeling shall contain the following statement in the directions § 329.1 Habit-forming drugs which are section: ``Consult a physician for use in chemical derivatives of substances children under 6 years of age.'' specified in section 502(d) of the (h) When the direction regarding age Federal Food, Drug, and Cosmetic in paragraph (e) or (f) of this section Act.
    [Show full text]
  • 483 Administrative Records, Texas Department of Criminal Justice
    Consistent with the terms of the Court’s May 22, 2017 scheduling order, the record has been redacted for all information that plaintiff, Texas Department of Criminal Justice (Texas), has identified as confidential. In addition, Defendants have also redacted information that the drug’s supplier and broker have separately advised the agency they consider confidential and private, as well as information the agency itself generally treats as confidential. This information has been redacted pending final FDA’s review of confidentiality claims, and our filing of the record with these redactions does not necessarily reflect our agreement with all of the claims of confidentiality Defendants have received. Defendants explicitly reserve the right to make an independent determination regarding the proper scope of redactions at a later time. Should we identify any of Texas’s redactions that are over-broad or otherwise improper, we will work with Texas’s counsel to revise the redactions in the record. Exhibit 14 FDA 095 Case 1:11-cv-00289-RJL Document 13-3 Filed 04/20/11 Page 1 of 74 CERTJFICATE Pursuant to the provisions ofRule 44 ofthe Federal Rules ofCivil Procedure, I hereby certifY that John Verbeten, Director ofthe Operations and Policy Branch, Division of Import Operations and Policy, Office ofRegional Operations, Office ofRegulatory Affairs, United States Food and Drug Administration, whose declaration is attached, has custody ofofficial records ofthe United States Food and Drug Administration. In witness whereof, I have, pursuant to the provision ofTitle 42, United States Code, Section 3505, and FDA StaffManual Guide 1410.23, hereto set my hand and caused the seal ofthe Department ofHealth and Human Services to be affixed th.is ~oi{.
    [Show full text]
  • Terminology and Information on Drugs Third Edition
    Terminology and Information on Drugs Third edition Terminology and Information on Drugs Third edition UNITED NATIONS NEW YORK, 2016 UNITED NATIONS PUBLICATION Sales No. E.16.XI.8 ISBN: 978-92-1-148287-4 eISBN: 978-92-1-057914-8 Original language: English © United Nations, March 2016. All rights reserved, worldwide The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. This publication has not been formally edited. Publishing production: English, Publishing and Library Section, United Nations Office at Vienna. Photographs: UNODC and Health Sciences Authority, Singapore. ACKNOWLEDGEMENTS UNODC’s Laboratory and Scientific Section (LSS), headed by Dr. Justice Tettey, wishes to express its appreciation and thanks to the following experts who participated in an expert group meeting and/or contributed to the development and review of this revision of Terminology and Information on Drugs: Dr. Heesun Chung Graduate School of Analytical Science and Technology (GRAST), South Korea Prof. Les Iversen Advisory Council on the Misuse of Drugs (ACMD), United Kingdom Dr. Wendy Lim Jong Lee Health Sciences Authority, Singapore Dr. Franco Tagliaro University of Verona, Italy Mr. Eleuterio Umpiérrez Faculty of Chemistry, Universidad de la República, Uruguay Mr. Scott Oulton DEA Office of Forensic Sciences, United States The preparation of this manual was coordinated by Dr. Conor Crean, Dr. Iphigenia Naidis and Ms. Susan Ifeagwu, staff of LSS.
    [Show full text]
  • Am1434 Am1434 Lb236 Lb236 Ajc - 05/12/2021 Ajc - 05/12/2021
    AM1434 AM1434 LB236 LB236 AJC - 05/12/2021 AJC - 05/12/2021 AMENDMENTS TO LB236 (Amendments to AM1388) Introduced by Hansen, B., 16. 1 1. Insert the following new sections: 2 Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 3 2020, is amended to read: 4 28-401 As used in the Uniform Controlled Substances Act, unless the 5 context otherwise requires: 6 (1) Administer means to directly apply a controlled substance by 7 injection, inhalation, ingestion, or any other means to the body of a 8 patient or research subject; 9 (2) Agent means an authorized person who acts on behalf of or at the 10 direction of another person but does not include a common or contract 11 carrier, public warehouse keeper, or employee of a carrier or warehouse 12 keeper; 13 (3) Administration means the Drug Enforcement Administration of the 14 United States Department of Justice; 15 (4) Controlled substance means a drug, biological, substance, or 16 immediate precursor in Schedules I through V of section 28-405. 17 Controlled substance does not include distilled spirits, wine, malt 18 beverages, tobacco, hemp, or any nonnarcotic substance if such substance 19 may, under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 301 et 20 seq., as such act existed on January 1, 2014, and the law of this state, 21 be lawfully sold over the counter without a prescription; 22 (5) Counterfeit substance means a controlled substance which, or the 23 container or labeling of which, without authorization, bears the 24 trademark, trade name, or other identifying mark,
    [Show full text]
  • The Safer Management of Controlled Drugs: Update Report for 2017 2 Contents
    The safer management of controlled drugs Annual update 2017 Published July 2018 The Care Quality Commission The Care Quality Commission is the independent regulator of health and adult social care in England. We make sure that health and social care services provide people with safe, effective, compassionate, high-quality care and we encourage care services to improve. Our role • We register health and adult social care providers. • We monitor and inspect services to see whether they are safe, effective, caring, responsive and well-led, and we publish what we find, including quality ratings. • We use our legal powers to take action where we identify poor care. • We speak independently, publishing regional and national views of the major quality issues in health and social care, and encouraging improvement by highlighting good practice. We also have a statutory duty to oversee the safe management arrangements for controlled drugs in England. Our values • Excellence – being a high performing organisation. • Caring – treating everyone with dignity and respect. • Integrity – doing the right thing. • Teamwork – learning from each other to be the best we can. Care Quality Commission The safer management of controlled drugs: Update report for 2017 2 Contents Introduction ..................................................................................................... 4 Overview and recommendations ................................................................... 4 Progress on recommendations from the 2016 report .................................
    [Show full text]
  • Drug of Abuse Cut Off Values
    Swedish Laboratory Services – Chemistry Department Drugs of Abuse Concentrations of Compounds that Produce a Result Approximately Equivalent to the Cut-off Value. Drug Category: Amphetamines Compound/Drug Cut-off Unit: ng/mL d-amphetamine 1000 d,l-methamphetamine 1500 d,l-amphetamine 1961 l-methamphetamine 1798 l-amphetamine 8651 MDA 3794 MDMA 13037 MDEA 11192 Unit: μg/mL 4-chloramphetamine 8.2 benzphetamine* 1.3 bupropion 814 chloroquine 3233 l-ephedrine 2240 fenfluramine 75 mephentermine 22.2 methoxyphenamine 231 nor-pseudoephedrine 142 phenmetrazine 6.9 phentermine 16.8 phenylpropanolamine 2000 propranolol 306 d,l-pseudoephedrine 4340 quinacrine 5696 tranylcypromine 85 tyramine 390 * Benzphetamine metabolized to amphetamine and methamphetamine. CHEM.09.909 Advia 1650 Drug of Abuse Cut-off Values Swedish Laboratory Services – Chemistry Department Drug Category: Benzodiazepine Compound/Drug Cut-off Unit: ng/mL alprazolam 65 7-aminoclonazepam 2600 7-aminoflunitrazepam 590 bromazepam 630 chlordiazepoxide 3300 clobazam 260 clonazepam 580 clorazepate * clotiazepam 380 demoxepam 1600 N-desalkylflurazepam 130 N-desmethyldiazepam 110 diazepam 70 estazolam 90 flunitrazepam 140 flurazepam 190 halazepam 110 α-hydroxyalprazolam 100 α-hydroxyalprazolam glucuronide† 110 1-N-hydroxyethlylflurazepam 150 α-hydroxytriazolam 130 ketazolam 100 lorazepam 600 lorazepam glucuronide† >20,000 medazepam 150 midazolam 130 nitrazepam 320 norchlordiazepoxide 2600 oxazepam 250 oxazepam glucuronide† >50,000 prazepam 90 temazepam 140 temazepam glucuronide† 6900 tetrazepam 70 triazolam 130 * Clorazepate degrades rapidly in stomach acid to nordiazepam. Nordiazepam hydroxylates to oxazepam. † The glucuronide metabolite of α-hydroxyalprazolam cross-reacts with this method. Other glucuronide metabolites, such as lorazepam, oxazepam, and temazepam cross-react to a limited extent. The cross-reactivity of other glucuronide metabolites with this method is not known.
    [Show full text]
  • 210 PART 329—HABIT-FORMING DRUGS Subpart A
    § 329.1 21 CFR Ch. I (4±1±97 Edition) container label and that are not mar- (h) When the direction regarding age keted in another retail package (e.g., in paragraph (e) or (f) of this section an outer box), the statement of the per- differs from an age-limiting direction centage of alcohol present in the prod- contained in any OTC drug monograph uct shall appear prominently and con- in this chapter, the direction contain- spicuously on the ``principal display ing the more stringent age limitation panel'' of the immediate container shall be used. label. (c) For products whose principal dis- PART 329ÐHABIT-FORMING DRUGS play panel is on the retail package and the retail package is not the imme- Subpart AÐDerivatives Designated as diate container, the statement of the Habit Forming percentage of alcohol present in the product shall also appear on the imme- Sec. diate container label; it may appear 329.1 Habit-forming drugs which are chemi- anywhere on that label in accord with cal derivatives of substances specified in section 502(e) of the Federal Food, section 502(d) of the Federal Food, Drug, Drug, and Cosmetic Act. and Cosmetic Act. (d) The statement expressing the Subpart BÐLabeling amount (percentage) of alcohol present in the product shall be in a size reason- 329.10 Labeling requirements for habit- ably related to the most prominent forming drugs. printed matter on the panel or label on which it appears, and shall be in lines Subpart CÐExemptions generally parallel to the base on which 329.20 Exemption of certain habit-forming the package rests as it is designed to be drugs from prescription requirements.
    [Show full text]